Trending Health

While the health industry is not always an early adopter of new technologies, the growth of generative artificial intelligence (GenAI) has empowered organizations to start transforming their AI aspirations into actions. In this episode, Mindy and Jen are joined by Vynamic’s Innovation Lead, Michael Hudson, and Responsible AI Lead, Todd Quartiere, to discuss where we see health organizations experimenting with AI and what it will take for them to achieve their long-term AI ambitions.

To learn more about implementing AI within your organization, check out our recent insight: Why AI fails or flourishes: The underestimated role of culture.

Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT

Source Links:

• The Unexpected Winners of the ChatGPT Generative AI Revolution 

Panel – Jen Burke, Michael Hudson, Mindy McGrath, Todd Quartiere

Research & Production – Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, the role bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues.

Podcast Tags: healthcare, healthcare news, life sciences, public health, France, medical, bacteria, cancer, immunotherapy, chemotherapy, microbiome, rare disease, Germany, Italy, health disparity 

Source Links:

• Dutch hospitals use AI to solve no-show patient problems that cost them millions  

Panel – Jack Young, Jen Burke, Ollie May  

Recording & Editing – Mike Liberto, Rachel Skonecki  

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss why pharmaceutical organizations should be paying attention to sustainability goals, some innovative practices underway, and what leaders should be considering as they embed more sustainable practices into their organizations. 

Podcast Tags: healthcare, life sciences, sustainability, healthcare news, climate change, climate crisis, emissions, net zero, supply chain 

Source Links: 

• Striving for sustainable drug discovery using Green Chemistry 

Panel – Oliver May, Rosanna Vellacott, Matt O’Dell 

Research & Production – Adrea Cope, Everly Petruzzelli, Oliver May  

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally, we discuss a groundbreaking procedure in which a kidney from a CRISPR gene edited pig was transplanted into a human.

Podcast Tags: healthcare, healthcare news, CVS health, PBMs, biosimilars, 340B, pharmacies, hospitals, providers, xenotransplantation, CRISPR, gene editing

Source Links:

• As Humira biosimilars take over the market, CVS has created a new ploy; the drug “rebate credit”
• Federal appeals court sides with 340B contract pharmacies 
• American Hospital Association 340B Factsheet 
• Gene edited pig kidney transplanted into a living patient for the first time
• Kidney Disease Statistics for the United States 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

One of the core tenets of the omnichannel philosophy is continuous learning and refinement – bringing together experience and data to evolve the marketing and model. Jen is joined by Vynamic’s Customer Experience Transformation Lead Mike Zapiec and Omnichannel Offering Lead Josh Padams to discuss what we’ve learned partnering with clients to build their omnichannel capabilities and what Life Sciences organizations can do to take their customer engagement to the next level.   

For more information on Vynamic’s work in Customer Experience Transformation, check out our service page:  

Podcast Tags: omnichannel, customer engagement, customer experience, marketing, healthcare, life sciences

Panel – Mike Zapiec, Josh Padams, Jen Burke

Research & Production – Hannah Yee, Aisling McAtamney, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK\’s Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe\’s mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe. 

Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI, chatbots, mental health, patient care, Spain, supply chain 

Source Links: 

• UK lacks plans to make pandemic vaccines quickly, MPs hear 

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy and Jen are joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Health Plans, Saurabh Raman, to talk about the growth and challenges obesity medications present for the health industry.

Podcast Tags: healthcare, obesity, weight loss, diabetes, health services, health plans, life sciences  

Source Links: 

• What Is Ozempic and Why Is It Getting So Much Attention? 
• We Know Where New Weight Loss Drugs Came From, but Not Why They Work 
• What the Scientists Who Pioneered Weight-Loss Drugs Want You to Know 
• Supply Updates about Wegovy
• The increase in appetite for obesity drugs 
• Demand for GLP-1 drugs is growing. Here\’s why payers are hesitant to cover them for weight loss 
• More than 4,000 ads for Ozempic-style drugs found running on Instagram and Facebook  
• Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs 
• Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that 
• Cost isn’t the only reason Medicare doesn’t cover Wegovy
• New marketing push by Ozempic and others sparks body-positive backlash 
• What You Need to Know About Compounded Versions of Popular Weight Loss Drugs 
• Novo antes up $16.5B to poach CDMO giant Catalent amid Wegovy surge  
• Wegovy, other GLP-1s could lower heart disease: Study  
• Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics  
• How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy  
• Novo Nordisk\’s Wegovy bonanza looms large in Denmark  
• Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion  
• Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect  
• Ozempic vs Wegovy 
• Obesity drug boom pushes Novo Nordisk shares to record high 
• Popular use of obesity drugs like Ozempic could change consumer habits 

Panel – Jen Burke, Mindy McGrath, Karen Baldry, Saurabh Raman 

Research & Production – Adrea Cope, Everly Petruzzelli 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year.

For more perspective on the Inflation Reduction Act\’s impact on Life Sciences companies, check out Mindy’s article in Pharmaphorum, "Seizing the moment: The life sciences industry at the threshold of change”.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, inflation reduction act, drug prices, pharmaceutical

Panel – Jen Burke, Mindy McGrath

Research & Production – Jen Burke, Mindy McGrath

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on the Medicare Prescription Payment Plan and a new report from Reuters that revealed the dramatic increase in new drug prices throughout 2023.

Podcast Tags: healthcare, healthcare news, IVF, embryos, supreme court, reproductive health, life sciences, health policy, inflation reduction act, CMS, medicare, medicaid, drug prices, pharmaceutical 

Source Links: 

• The science of IVF: What to know about Alabama\’s \’extrauterine children\’ ruling  

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke  

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention. 

Podcast Tags: healthcare, healthcare news, life sciences, precision oncology, cancer, molecular testing, infectious diseases, vaccination, NHS sustainability, innovation, Sweden 

Source Links:

• We’re naming cancers all wrong, oncology leader says  

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.